111 Total Current Assets 2018-2024 | YI
111 Annual Total Current Assets (Millions of US $) |
|
---|---|
2024 | $363 |
2023 | $413 |
2022 | $469 |
2021 | $440 |
2020 | $440 |
2019 | $213 |
2018 | $219 |
2017 | $110 |
111 Quarterly Total Current Assets (Millions of US $) |
|
---|---|
2024-12-31 | $363 |
2024-09-30 | $411 |
2024-06-30 | $365 |
2024-03-31 | $386 |
2023-12-31 | $413 |
2023-09-30 | $438 |
2023-06-30 | $391 |
2023-03-31 | $440 |
2022-12-31 | $469 |
2022-09-30 | $392 |
2022-06-30 | $420 |
2022-03-31 | $424 |
2021-12-31 | $440 |
2021-09-30 | $433 |
2021-06-30 | $458 |
2021-03-31 | $432 |
2020-12-31 | $440 |
2020-09-30 | $382 |
2020-06-30 | $249 |
2020-03-31 | $213 |
2019-12-31 | $213 |
2019-09-30 | $217 |
2019-06-30 | $240 |
2019-03-31 | $225 |
2018-09-30 | $241 |
2017-12-31 | $110 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.067B | $1.973B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.320B | 52.93 |
Hims & Hers Health (HIMS) | United States | $11.979B | 124.46 |
Tempus AI (TEM) | United States | $10.204B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.547B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.305B | 67.26 |
Privia Health (PRVA) | United States | $2.816B | 192.50 |
Enovis (ENOV) | United States | $1.849B | 10.31 |
Clover Health Investments (CLOV) | United States | $1.669B | 0.00 |
Schrodinger (SDGR) | United States | $1.550B | 0.00 |
Phreesia (PHR) | United States | $1.447B | 0.00 |
Omnicell (OMCL) | United States | $1.351B | 23.83 |
Azenta (AZTA) | United States | $1.283B | 59.64 |
10x Genomics (TXG) | United States | $1.052B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
Butterfly Network (BFLY) | United States | $0.529B | 0.00 |
Claritev (CTEV) | United States | $0.479B | 0.00 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Talkspace (TALK) | United States | $0.462B | 138.00 |
Standard BioTools (LAB) | United States | $0.363B | 0.00 |
TruBridge (TBRG) | United States | $0.356B | 789.67 |
Outset Medical (OM) | United States | $0.327B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.283B | 0.00 |
Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
Pulmonx (LUNG) | United States | $0.126B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.097B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.31 |
P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |